Goldman Sees 2016 'Flight To Quality' In These Biotech Stocks

By: via Benzinga
Smid-cap biotech shares have pulled back significantly since July 2015. Goldman Sachs’ Salveen Richter initiated ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.